A panelist discusses how comprehensive care coordination between specialists, proactive adverse effect management, and innovative care models can optimize treatment outcomes for Lambert-Eaton ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Simple reaction time tasks given to patients living with glaucoma had different response times based on whether the task was visual or auditory, according to a new study published in the European ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

Industry Committee filed a legal challenge against the Minnesota Department of Commerce, arguing that Minnesota’s Pharmacy Benefit Manager (PBM) Licensure and Regulation Act illegally interfered with ...

For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and ...

Song Park, MD, University of Washington Medicine, advocates for more user-friendly technology to support equitable skin cancer care access.

Lockdowns instituted due to the COVID-19 pandemic could have brought about exacerbated immune responses in people living with ...

The VET PFAS Act could help older veterans with toxic exposure attain the medical treatment they need by expanding ...

Sikander Ailawadhi, MD, discusses how the 2024 ASH Annual Meeting’s “Prospective Patient Preference Study for BTKi Treatment Attributes in CLL and SLL” explored the factors influencing patient ...

Wendy Cheng, PhD, MPH, discusses how the study on the efficacy of gepotidacin vs nitrofurantoin in a nitrofurantoin-resistant population (a pooled analysis of the EAGLE-2 and EAGLE-3 trials) aimed to ...